This page shows the latest Celexa news and features for those working in and with pharma, biotech and healthcare.
protection for Abilify and former blockbuster antidepressant Lexapro/Celexa (escitalopram).
Court upholds 94m fine for paying off firms to delay launch of Celexa generics. ... Lundbeck insists it did not go beyond the protection already offered by its patent rights on Celexa.
which it hopes will restore growth after the loss of patent protection on US blockbuster antidepressant Lexapro/Celexa (escitalopram).
Compounding this has been a legal battle with the European Commission, which ruled that Lundbeck collaborated with several other companies to delay the entry of generic competition for Celexa/ Cipramil (citalopram).
A case involving AstraZeneca and Nycomed was dropped last year. Earlier this year Danish pharma company Lundbeck was fined almost 94m for a pay-for-delay deal involving its antidepressant
its big-selling antidepressant Celexa/ Cipramil (citalopram).
More from news
Approximately 1 fully matching, plus 12 partially matching documents found.
OPEN Health is a family of expert practices, working in partnership to drive positive change in healthcare communications & market...